Skip to main content
. 2020 Apr 21;13:49–61. doi: 10.2147/IBPC.S245068

Table 3.

Antihypertensive Therapy and Lifestyle Related Factors Among Patients on Follow Up at NRH, 2018

Variables Category Frequency Percent
Duration of therapy (years) <5 125 42.1
5 – 10 101 34
≥10 71 23.9
Medications Monotherapy
(n=147)
Enalapril 113 38.0
Hydrochlorothiazide 23 7.7
Nifedepine 11 3.7
Drug Combination
(n=150)
Hydrochlorothiazide+ Enalapril 109 36.7
Hydrochlorothiazide+ Nifedepine 2 0.7
Hydrochlorothiazide+ Propranolol 1 0.3
Enalapril + Nifedepine 33 11.1
Enalapril + Atenolol 4 1.3
Enalapril + Propranolol 1 0.3
Source of medication Self-sponsored 131 44.1
Free of charge 123 41.4
By sponsorship 43 14.5
Side effect Yes 91 30.6
No 206 69.4
Experienced Side effect
(n=91)
Weakness 34 37.36
Headache 24 26.37
Dry mouth 14 15.38
Erectile dysfunction 8 8.79
GI complaint 3 3.3
Cough 3 3.3
Others* 4 4.4

Notes: *Others: Postural hypertension, Edema, Loss of appetite, Foot pain

Abbreviations: GI, gastro-intestinal; NRH, Nekemte Referral Hospital.